Engano, Rovelyn T.

HRN: 17-83-03  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/28/2026
CEFUROXIME 1.5GM (VIAL)
06/28/2026
06/28/2026
IV
1.5 Grams
Q8 X 3 Doses
SP NSD W RMLE
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines